Works matching AU Ye, June

Results: 13

Body mass index and clinical response to intravenous or subcutaneous abatacept in patients with rheumatoid arthritis.

Published in:

Clinical Rheumatology, 2017, v. 36, n. 12, p. 2655, doi. 10.1007/s10067-017-3788-1

By:

D'Agostino, Maria-Antonietta;
Alten, Rieke;
Mysler, Eduardo;
Bars, Manuela;
Ye, June;
Murthy, Bindu;
Heitzmann, Julia;
Vadanici, Radu;
Ferraccioli, Gianfranco

Publication type:

Article

Determining MRI Inflammation Targets When Considering a Rheumatoid Arthritis Treat-to-Target Strategy: Results of a Randomized, Placebo-Controlled Trial.

Published in:

2019

By:

Ahmad, Harris A.;
Baker, Joshua F.;
Østergaard, Mikkel;
Ye, June;
Emery, Paul;
Conaghan, Philip G.

Publication type:

journal article

Deucravacitinib in Moderate to Severe Psoriasis: Clinical and Quality-of-Life Outcomes in a Phase 2 Trial.

Published in:

Dermatology & Therapy, 2022, v. 12, n. 2, p. 495, doi. 10.1007/s13555-021-00649-y

By:

Thaçi, Diamant;
Strober, Bruce;
Gordon, Kenneth B.;
Foley, Peter;
Gooderham, Melinda;
Morita, Akimichi;
Papp, Kim A.;
Puig, Lluís;
Menter, M. Alan;
Colombo, Matthew J.;
Elbez, Yedid;
Kisa, Renata M.;
Ye, June;
Napoli, Andrew A.;
Wei, Lan;
Banerjee, Subhashis;
Merola, Joseph F.;
Gottlieb, Alice B.

Publication type:

Article

The Emerge and Evolution of the Concept "Junfa" in Early Republican China.

Published in:

Thought & Words / Sī yǔ Yán, 2022, v. 60, n. 4, p. 54

By:

Ye-June Chao

Publication type:

Article

Remogliflozin Etabonate, a Selective Inhibitor of the Sodium-Glucose Transporter 2, Improves Serum Glucose Profiles in Type 1 Diabetes.

Published in:

Diabetes Care, 2012, v. 35, n. 11, p. 2198, doi. 10.2337/dc12-0508

By:

MUDALIAR, SUNDER;
ARMSTRONG, DEBRA A.;
MAVIAN, ANNIE A.;
O'CONNOR-SEMMES, ROBIN;
MYDLOW, PATRICIA K.;
YE, JUNE;
HUSSEY, ELIZABETH K.;
NUNEZ, DEREK J.;
HENRY, ROBERT R.;
DOBBINS, ROBERT L.

Publication type:

Article

Type 2 diabetes mellitus development programs in the new regulatory environment with cardiovascular safety requirements.

Published in:

Diabetes, Metabolic Syndrome & Obesity: Targets & Therapy, 2015, v. 8, p. 315, doi. 10.2147/DMSO.S84005

By:

Yang, Fred;
Stewart, Murray;
Ye, June;
DeMets, David

Publication type:

Article

Potential modification of the UKPDS risk engine and evaluation of macrovascular event rates in controlled clinical trials.

Published in:

Diabetes, Metabolic Syndrome & Obesity: Targets & Therapy, 2013, v. 6, p. 247, doi. 10.2147/DMSO.S43724

By:

Fred Yang;
June Ye;
Pomerantz, Kenneth;
Stewart, Murray

Publication type:

Article

Immune checkpoint inhibition in sepsis: a Phase 1b randomized study to evaluate the safety, tolerability, pharmacokinetics, and pharmacodynamics of nivolumab.

Published in:

2019

By:

Hotchkiss, Richard S.;
Colston, Elizabeth;
Yende, Sachin;
Crouser, Elliott D.;
Martin, Greg S.;
Albertson, Timothy;
Bartz, Raquel R.;
Brakenridge, Scott C.;
Delano, Matthew J.;
Park, Pauline K.;
Donnino, Michael W.;
Tidswell, Mark;
Mayr, Florian B.;
Angus, Derek C.;
Coopersmith, Craig M.;
Moldawer, Lyle L.;
Catlett, Ian M.;
Girgis, Ihab G.;
Ye, June;
Grasela, Dennis M.

Publication type:

journal article

HARMONY 4: randomised clinical trial comparing once-weekly albiglutide and insulin glargine in patients with type 2 diabetes inadequately controlled with metformin with or without sulfonylurea.

Published in:

Diabetologia, 2014, v. 57, n. 12, p. 2475, doi. 10.1007/s00125-014-3360-3

By:

Weissman, Peter;
Carr, Molly;
Ye, June;
Cirkel, Deborah;
Stewart, Murray;
Perry, Caroline;
Pratley, Richard

Publication type:

Article

A randomized dose-finding study demonstrating the efficacy and tolerability of albiglutide in Japanese patients with type 2 diabetes mellitus.

Published in:

Current Medical Research & Opinion, 2014, v. 30, n. 6, p. 1095, doi. 10.1185/03007995.2014.896327

By:

Seino, Yutaka;
Inagaki, Nobuya;
Miyahara, Hajime;
Okuda, Inaha;
Bush, Mark;
Ye, June;
Holland, M. Claire;
Johnson, Susan;
Lewis, Eric;
Nakajima, Hiromu

Publication type:

Article

Haemodynamic effects of the nitroxyl donor cimlanod (BMS-986231) in chronic heart failure: a randomized trial.

Published in:

2021

By:

Lang, Ninian N.;
Ahmad, Faheem A.;
Cleland, John G.;
O'Connor, Christopher M.;
Teerlink, John R.;
Voors, Adriaan A.;
Taubel, Jorg;
Hodes, Anke R.;
Anwar, Mohamed;
Karra, Ravi;
Sakata, Yasushi;
Ishihara, Shiro;
Senior, Roxy;
Khemka, Abhishek;
Prasad, Narayana G.;
DeSouza, Mary M.;
Seiffert, Dietmar;
Ye, June Y.;
Kessler, Paul D.;
Borentain, Maria

Publication type:

journal article

Efficacy of Abatacept and Adalimumab in Patients with Early Rheumatoid Arthritis With Multiple Poor Prognostic Factors: Post Hoc Analysis of a Randomized Controlled Clinical Trial (AMPLE).

Published in:

Rheumatology & Therapy, 2019, v. 6, n. 4, p. 559, doi. 10.1007/s40744-019-00174-7

By:

Fleischmann, Roy;
Weinblatt, Michael;
Ahmad, Harris;
Maldonado, Michael A.;
Alemao, Evo;
Ye, June;
Schiff, Michael

Publication type:

Article

Baseline Objective Inflammation by Magnetic Resonance Imaging as a Predictor of Therapeutic Benefit in Early Rheumatoid Arthritis With Poor Prognosis.

Published in:

2020

By:

Ahmad, Harris A.;
Baker, Joshua F.;
Østergaard, Mikkel;
Emery, Paul;
Durez, Patrick;
Ye, June;
Banerjee, Subhashis;
Conaghan, Philip G.

Publication type:

journal article